Elizabeth and Michael Ruane have been extremely generous benefactors, not only to ITOG, but also to the medical community at large. At the end of July, Massachusetts General Hospital hosted a celebration in recognition of Elizabeth and Michael Ruane’s generosity. The event included the announcement of the Elizabeth and Michael Ruane Center for Endocrine Tumors and recognition of its inaugural incumbent: Lori J. Wirth, MD, Elizabeth and Michael Ruane Endowed Chair in Medical Oncology. They also announced the recipients of the Elizabeth and Michael Ruane Endowed Fellows in Surgery and the winners of the Gilbert H. Daniels, MD Award for Innovative Research in Thyroid Cancer. We are all indebted to Elizabeth and Michael Ruane for their philanthropy.
To catalyze a cure for the most challenging thyroid cancers through the collaborative efforts of our unique multidisciplinary team of leading physicians, scientists, and advocates to design, coordinate, and prioritize state-of-the-art clinical trials and correlative science.